Passivating the Background of Living Microbes with a Zwitterionic Peptide for Therapies
Living microbial therapies have been proposed as a course of action for a variety of diseases. However, problematic interactions between the host immune system and the microbial organism present significant clinical concerns. Previously, we developed a genetically encoded superhydrophilic zwitterionic peptide, termed EKP, to mimic low-immunogenic zwitterionic materials, which have been used for the chemical modification of biologics such as protein and nucleic acid drugs to increase their in vivo circulation time and reduce their immunogenicity. Herein, we demonstrate the protective effects of the EKP polypeptide genetically cloaking the surface of Saccharomyces cerevisiae as a model microbe in both in vitro and in vivo systems. First, we show that EKP peptide cloaking suppresses the interactions between yeast cells and their specific antibodies, thereby illustrating its cloaking behavior. Then, we examine the in vitro interactions between EKP peptide surface cloaked yeast cells and murine macrophage cells, which exhibit phagocytotic behavior in the presence of foreign microbes. Our results indicate that EKP cloaking suppresses macrophage interactions and thus reduces phagocytosis. Furthermore, EKP cloaked yeast cells demonstrate a prolonged circulation time in mice in vivo.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Bioconjugate chemistry - (2024) vom: 08. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fang, Liang [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 08.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1021/acs.bioconjchem.3c00549 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369463412 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369463412 | ||
003 | DE-627 | ||
005 | 20240308233514.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240308s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acs.bioconjchem.3c00549 |2 doi | |
028 | 5 | 2 | |a pubmed24n1320.xml |
035 | |a (DE-627)NLM369463412 | ||
035 | |a (NLM)38456602 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fang, Liang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Passivating the Background of Living Microbes with a Zwitterionic Peptide for Therapies |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 08.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Living microbial therapies have been proposed as a course of action for a variety of diseases. However, problematic interactions between the host immune system and the microbial organism present significant clinical concerns. Previously, we developed a genetically encoded superhydrophilic zwitterionic peptide, termed EKP, to mimic low-immunogenic zwitterionic materials, which have been used for the chemical modification of biologics such as protein and nucleic acid drugs to increase their in vivo circulation time and reduce their immunogenicity. Herein, we demonstrate the protective effects of the EKP polypeptide genetically cloaking the surface of Saccharomyces cerevisiae as a model microbe in both in vitro and in vivo systems. First, we show that EKP peptide cloaking suppresses the interactions between yeast cells and their specific antibodies, thereby illustrating its cloaking behavior. Then, we examine the in vitro interactions between EKP peptide surface cloaked yeast cells and murine macrophage cells, which exhibit phagocytotic behavior in the presence of foreign microbes. Our results indicate that EKP cloaking suppresses macrophage interactions and thus reduces phagocytosis. Furthermore, EKP cloaked yeast cells demonstrate a prolonged circulation time in mice in vivo | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Cai, Simian |e verfasserin |4 aut | |
700 | 1 | |a McMullen, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Hsu, Yi-Chen |e verfasserin |4 aut | |
700 | 1 | |a Chen, Michelle Yi Qin |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Shaoyi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioconjugate chemistry |d 1992 |g (2024) vom: 08. März |w (DE-627)NLM012617032 |x 1520-4812 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:08 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.bioconjchem.3c00549 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 08 |c 03 |